Both US List And Net Drug Price Increases Have Been Substantial, JAMA Study Finds

A new study looks at list drug price increases and manufacturer discounts over 11 years and finds that despite significant rebates, net price increases still grew 3.5 times more than inflation.

A man changes the position of a block with symbols of growth and decline in price — The price of brand drugs increased substantially over 11 years • Source: Shutterstock

List and net drug price increases in the US have been substantial over 11 years from 2007 to 2018, and although manufacturer rebates did offset list drug price increases by 62%, net drug prices still increased 3.5 times more than inflation over that timeframe, according to a study published in the Journal of The American Medical Association.

The study by University of Pittsburgh's Inmaculada Hernandez, et. al and published in JAMA on 3 March looked at list...